Literature DB >> 34759356

SBRT feasible for oligometastatic RCC.

Peter Sidaway1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34759356     DOI： 10.1038/s41571-021-00582-1

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial.

Authors:  Chad Tang; Pavlos Msaouel; Kieko Hara; Haesun Choi; Venus Le; Amishi Y Shah; Jennifer Wang; Eric Jonasch; Seungtaek Choi; Quynh-Nhu Nguyen; Prajnan Das; Surendra Prajapati; Zhiqian Yu; Khaja Khan; Steven Powell; Ravi Murthy; Kanishka Sircar; Nizar M Tannir
Journal:  Lancet Oncol       Date:  2021-10-28       Impact factor: 41.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.